The News
Natural Field announced results from a Phase I study on joint health, showing their glucosamine-chondroitin co-loaded liposomes improved cartilage repair in a zebrafish model. The study was conducted by an AAALAC accredited CRO and completed in May 2026. Ten samples were tested, with Sample 5 achieving the highest repair rate of 55% in cartilage injury recovery.
A pre‑clinical joint‑health study has caught my eye. While its focus seems distant from bars and liquor stores, the same ingredients used to heal cartilage in zebrafish could be incorporated into wellness drinks, sports‑nutrition shots, or low‑proof functional spirits. Operators need to decide whether a 55 % repair rate in an animal model signals a viable ingredient for new functional beverages, or if it will fade as a lab headline before reaching distributors.
Natural Field Biotech reports that its glucosamine‑chondroitin liposome formulation achieved a 55 % cartilage repair rate in zebrafish (Sample 5). That figure is strong for a Phase I animal model but remains preclinical. What matters next is whether that percentage translates into human clinical outcomes and meets FDA and EU supplement regulatory expectations, which now require evidence beyond zebrafish models.
The global glucosamine‑chondroitin supplement market was $2.5 billion in 2023 and is projected to grow at a 7–8 % CAGR through 2030. This indicates that joint‑health products occupy a mature, competitive space where new entrants need compelling clinical evidence to secure shelf space or brand partnerships. If Natural Field secures human trials that confirm its zebrafish results, the product will align with an established distribution network in the supplement arena.
Natural Field’s upcoming presentation at CPHI China 2026 reflects an intention to enter Asian markets. For distributors, this could provide a new source of functional ingredients that may offer cost advantages due to regional production efficiencies. However, logistics such as raw‑material sourcing and cold‑chain requirements for liposomes must be carefully planned. Local labeling compliance remains critical.
There are two practical takeaways for operators. First, distributors who already carry joint‑health supplements should consider adding Natural Field’s formulation once they receive human clinical data that satisfies regulatory requirements. Second, bars and retailers expanding into the functional‑beverage market can view this ingredient as a potential halo product for wellness drinks or low‑proof spirits, but it is not ready to replace high‑proof offerings without clear efficacy evidence.
The 55 % repair rate in zebrafish shows promise, yet translating it into a product that meets $2.5 billion market demand and regulatory scrutiny remains the real challenge. Distributors who secure human clinical evidence for this formulation will be positioned to capture demand for joint‑health ingredients.
Original Press Release
Natural Field recently completed a Phase I scientific evaluation study on joint health functionality. The results demonstrated that glucosamine-chondroitin co-loading liposomes exhibited significant activity in a cartilage injury repair model, providing new scientific evidence for product innovation in joint health, sports nutrition, and healthy aging.
The study was conducted by a professional CRO accredited by AAALAC International and the testing report was finalized in May 2026. Using an internationally recognized patented zebrafish cartilage injury model, the study systematically evaluated ten samples, including Natural Field's glucosamine-chondroitin co-loaded liposomes.
According to the study's conclusions, under Phase I experimental conditions, all ten samples showed cartilage repair effects, as evidenced by increased cartilage fluorescence intensity and improved mobility.
In the cartilage repair evaluation, several samples demonstrated superior repair effects compared with the positive control, sodium chondroitin sulfate. Among them, Sample 5 showed the best performance, achieving a 55% cartilage injury repair rate, followed by Sample 2 at 50%, and Samples 3 and 4 both at 46%.
In the evaluation of locomotor behavior, Sample 5 achieved a 106% repair efficacy, Sample 2 reached 90%, and Samples 3 and 4 both reached 81%, indicating a significant potential to improve the mobility decline caused by cartilage injury.
As global populations age and demand for active aging solutions continues to expand, interest in joint health, cartilage protection, and long-term mobility support is growing rapidly. With advantages in safety, formulation flexibility, and sustainable product development, glucosamine-chondroitin co-loaded liposomes are attracting increasing attention as a next-generation ingredient solution for dietary supplements, functional foods, and specialized nutrition applications.
Natural Field has long focused on the development of functional ingredients and innovative health solutions. The results of this study further expand the company's scientific evidence base in the joint health category, providing a stronger foundation for future product innovation, formulation development, and market applications.
Welcoming Global Partners to CPhI China 2026Connecting with Global Partners at CPhI China 2026
As one of the most influential events in the global pharmaceutical and health industries, CPhI China 2026 is just around the corner. Natural Field Biotech Co., Ltd. will showcase a range of innovative natural health ingredients and its latest scientific research achievements at the exhibition.
At CPhI China 2026, the company will highlight its latest R&D advancements in natural functional ingredients across joint health, healthy aging, anti-aging, and innovative nutrition solutions. In addition, it will connect with global clients, partners, and industry experts to explore market trends and collaboration opportunities.
We sincerely invite customers and partners from around the world to visit us at Booth E4E38 for discussions and business opportunities, and to explore the future of innovation in the natural health industry together.
About Natural Field Biotech Co., Ltd.
Natural Field Biotech Co., Ltd. (Natural Field) is a high-tech company dedicated to the research, development, production, and global distribution of functional ingredients. With a strong focus on innovation and quality, Natural Field provides premium natural ingredient solutions for the food, dietary supplement, nutrition and wellness, and pharmaceutical sectors. The company supports global brands and manufacturers with reliable ingredients, technical expertise, and customized solutions for product development and market growth.
Source: PR Newswire